Integra Lifesciences Holdings (IART) Current Leases (2019 - 2026)

Integra Lifesciences Holdings has disclosed Current Leases across 8 years of filings, most recently posting $13.9 million for Q2 2026.

• In Q2 2026, Current Leases fell 1.81% year-over-year to $13.9 million; the TTM figure through Jun 2026 stood at $13.9 million (down 1.81% YoY), while the FY2025 annual figure was $14.0 million, down 3.58% from the prior year.
• Current Leases came in at $13.9 million for Q2 2026 at Integra Lifesciences Holdings, roughly flat from $13.9 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $16.3 million in Q1 2024 to a low of $12.7 million in Q2 2022.
• Average Current Leases over 5 years is $14.4 million, with a median of $14.4 million recorded in 2022.
• Year-over-year, Current Leases grew 14.71% in 2023 and slipped 13.08% in 2025.
• Over 5 years, Current Leases stood at $14.6 million in 2022, then gained by 4.51% to $15.3 million in 2023, then fell by 4.87% to $14.5 million in 2024, then retreated by 3.58% to $14.0 million in 2025, then slipped by 0.71% to $13.9 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $13.9 million in Q2 2026, $13.9 million in Q1 2026, and $14.0 million in Q4 2025.